[1]
J. . Hanžel, T. . Košir Božič, and R. . Janša, “Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study”, Radiol Oncol, vol. 54, no. 2, pp. 233–236, May 2020.